Absence of bacterially induced RELMβ reduces injury in the dextran sodium sulfate model of colitis

Journal of Clinical Investigation

Volumn 116, Issue 11, 2006, Pages 2914-2923

  McVay, Laila D ^a   Keilbaugh, Sue A ^a   Wong, Tracie M H ^b   Kierstein, Sonja ^a   Shin, Marcus E ^a   Lehrke, Michael ^a   Lefterova, Martina I ^a   Shifflett, D Edward ^c   Barnes, Sean L ^d   Cominelli, Fabio ^d   Cohn, Steven M ^d   Hecht, Gail ^c   Lazar, Mitchell A ^a   Haczku, Angela ^a   Wu, Gary D ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^d UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXTRAN; RESISTIN; SODIUM SULFATE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; COLITIS; COLON; CONTROLLED STUDY; DISEASE SEVERITY; ENTERITIS; GOBLET CELL; ILEUM; IN VITRO STUDY; IN VIVO STUDY; INTESTINE CELL; INTESTINE EPITHELIUM; INTESTINE MUCOSA; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; CELL MOVEMENT; CELL PROLIFERATION; COLITIS; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; EPITHELIAL CELLS; GENE EXPRESSION REGULATION; HORMONES, ECTOPIC; INFLAMMATION; LEUKOCYTE COUNT; LYMPHOCYTES; MACROPHAGES; MICE; MICE, KNOCKOUT;

EID: 33750585364     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI28121     Document Type: Article

References (47)

1. Steppan, C.M., et al. 2001. A family of tissue-specific resistin-like molecules. Proc. Natl. Acad. Sci. U. S. A. 98:502-506.
2. Steppan, C.M., and Lazar, M.A. 2004. The current biology of resistin. J. Intern. Med. 255:439-447.
3. Bokarewa, M., Nagaev, I., Dahlberg, L., Smith, U., and Tarkowski, A. 2005. Resistin, an adipokine with potent proinflammatory properties. J. Immunol. 174:5789-5795.
4. Silswal, N., et al. 2005. Human resistin stimulates the pro-inflammatory cytokines TNF-alpha and IL-12 in macrophages by NF-kappaB-dependent pathway. Biochem. Biophys. Res. Commun. 334:1092-1101.
5. Karmiris, K., et al. 2006. Circulating levels of leptin, adiponectin, resistin, and ghrelin in inflammatory bowel disease. Inflamm. Bowel Dis. 12:100-105.
6. He, W., et al. 2003. Bacterial colonization leads to the colonic secretion of RELMbeta/FIZZ2, a novel goblet cell-specific protein. Gastroenterology. 125:1388-1397.
7. Artis, D., et al. 2004. RELMbeta/FIZZ2 is a goblet cell-specific immune-effector molecule in the gastrointestinal tract. Proc. Natl. Acad. Sci. U. S. A. 101:13596-13600.
8. Wang, M.L., et al. 2004. Regulation of RELM/ FIZZ isoform expression by Cdx2 in response to innate and adaptive immune stimulation in the intestine. Am. J. Physiol. Gastrointest. Liver Physiol. 288:G1074-G1083.
9. Sartor, R.B. 1997. The influence of normal microbial flora on the development of chronic mucosal inflammation. Res. Immunol. 148:567-576.
10. Elson, C.O. 1999. Experimental models of intestinal inflammation: new insights into mechanisms of mucosal homeostasis. In Mucosal immunology. P.L. Ogra et al., editors. Academic Press. San Diego, California, USA. 1007-1024.
11. Podolsky, D.K. 2002. Inflammatory bowel disease. N. Engl. J. Med. 347:417-429.
12. Uhlig, H.H., and Powrie, F. 2003. Dendritic cells and the intestinal bacterial flora: a role for localized mucosal immune responses. J. Clin. Invest. 112:648-651. doi:10.1172/JCI200319545.
13. Isaacs, K.L., and Sartor, R.B. 2004. Treatment of inflammatory bowel disease with antibiotics. Gastroenterol. Clin. North Am. 33:335-345.
14. Ogura, Y., et al. 2001. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature. 411:603-606.
15. Hugot, J.P., et al. 2001. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature. 411:599-603.
16. Itoh, H., Beck, P.L., Inoue, N., Xavier, R., and Podolsky, D.K. 1999. A paradoxical reduction in susceptibility to colonic injury upon targeted transgenic ablation of goblet cells. J. Clin. Invest. 104:1539-1547.
17. Okayasu, I., et al. 1990. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology. 98:694-702.
18. Cooper, H.S., Murthy, S.N., Shah, R.S., and Sedergran, D.J. 1993. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab. Invest. 69:238-249.
19. Targan, S.R., et al. 1997. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group. N. Engl. J. Med. 337:1029-1035.
20. Myers, K.J., et al. 2003. Antisense oligonucleotide blockade of tumor necrosis factor-alpha in two murine models of colitis. J. Pharmacol. Exp. Ther. 304:411-424.
21. Renigunta, A., et al. 2006. Human RELMbeta is a mitogenic factor in lung cells and induced in hypoxia. FEBS Lett. 580:900-903.
22. Strober, W., Fuss, I.J., and Blumberg, R.S. 2002. The immunology of mucosal models of inflammation. Annu. Rev. Immunol. 20:495-549.
23. Hollander, D., et al. 1986. Increased intestinal permeability in patients with Crohn's disease and their relatives. A possible etiologic factor. Ann. Intern. Med. 105:883-885.
24. Yoshihara, K., Yajima, T., Kubo, C., and Yoshikai, Y. 2006. Role of interleukin 15 in colitis induced by dextran sulphate sodium in mice. Gut. 55:334-341.
25. Bamias, G., et al. 2005. Proinflammatory effects of TH2 cytokines in a murine model of chronic small intestinal inflammation. Gastroenterology. 128:654-666.
26. Norkina, O., Burnett, T.G., and De Lisle, R.C. 2004. Bacterial overgrowth in the cystic fibrosis transmembrane conductance regulator null mouse small intestine. Infect. Immun. 72:6040-6049.
27. Rath, H.C., et al. 2001. Different subsets of enteric bacteria induce and perpetuate experimental colitis in rats and mice. Infect. Immun. 69:2277-2285.
28. Dieleman, L.A., et al. 1994. Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice. Gastroenterology. 107:1643-1652.
29. Tessner, T.G., Cohn, S.M., Schloemann, S., and Stenson, W.F. 1998. Prostaglandins prevent decreased epithelial cell proliferation associated with dextran sodium sulfate injury in mice. Gastroenterology. 115:874-882.
30. Kitajima, S., Takuma, S., and Morimoto, M. 1999. Changes in colonic mucosal permeability in mouse colitis induced with dextran sulfate sodium. Exp. Anim. 48:137-143.
31. Goetz, F.W., Planas, J.V., and MacKenzie, S. 2004. Tumor necrosis factors. Dev. Comp. Immunol. 28:487-497.
32. Steppan, C.M., et al. 2001. The hormone resistin links obesity to diabetes. Nature. 409:307-312.
33. Rajala, M.W., Obici, S., Scherer, P.E., and Rossetti, L. 2003. Adipose-derived resistin and gut-derived resistin-like molecule-β selectively impair insulin action on glucose production. J. Clin. Invest. 111:225-230. doi:10.1172/JCI200316521.
34. Kushiyama, A., et al. 2005. Resistin-like molecule beta activates MAPKs, suppresses insulin signaling in hepatocytes, and induces diabetes, hyperlipidemia, and fatty liver in transgenic mice on a high fat diet. J. Biol. Chem. 280:42016-42025.
35. Wellen, K.E., and Hotamisligil, G.S. 2005. Inflammation, stress, and diabetes. J. Clin. Invest. 115:1111-1119. doi:10.1172/JCI200525102.
36. Hotamisligil, G.S., et al. 1996. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science. 271:665-668.
37. Uysal, K.T., Wiesbrock, S.M., Marino, M.W., and Hotamisligil, G.S. 1997. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature. 389:610-614.
38. Marini, M., et al. 2003. TNF-alpha neutralization ameliorates the severity of murine Crohn's-like ileitis by abrogation of intestinal epithelial cell apoptosis. Proc. Natl. Acad. Sci. U. S. A. 100:8366-8371.
39. Bamias, G., et al. 2002. Down-regulation of intestinal lymphocyte activation and Th1 cytokine production by antibiotic therapy in a murine model of Crohn's disease. J. Immunol. 169:5308-5314.
40. Mashimo, H., Wu, D.C., Podolsky, D.K., and Fishman, M.C. 1996. Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor. Science. 274:262-265.
41. Sonnenburg, J.L., Angenent, L.T., and Gordon, J.I. 2004. Getting a grip on things: how do communities of bacterial symbionts become established in our intestine? Nat. Immunol. 5:569-573.
42. Halm, D.R., and Halm, S.T. 2000. Secretagogue response of goblet cells and columnar cells in human colonic crypts. Am. J. Physiol. Cell Physiol. 278:C212-C233.
43. Shapiro, L., and Scherer, P.E. 1998. The crystal structure of a complement-1q family protein suggests an evolutionary link to tumor necrosis factor. Curr. Biol. 8:335-338.
44. Patel, S.D., Rajala, M.W., Rossetti, L., Scherer, P.E., and Shapiro, L. 2004. Disulfide-dependent multimeric assembly of resistin family hormones. Science. 304:1154-1158.
45. Silberg, D.G., et al. 2002. Cdx2 ectopic expression induces gastric intestinal metaplasia in transgenic mice. Gastroenterology. 122:689-696.
46. Wu, G.D., Lai, E.J., Huang, N., and Wen, X. 1997. Oct-1 and CCAAT/enhancer-binding protein (C/EBP) bind to overlapping elements within the interleukin-8 promoter. The role of Oct-1 as a transcriptional repressor. J. Biol. Chem. 272:2396-2403.
47. Louahed, J., et al. 2001. Interleukin 9 promotes influx and local maturation of eosinophils. Blood. 97:1035-1042.